Tracers / [18F]FDDNP

What it is

Compound class
PET radiotracer (naphthyl-malononitrile derivative)
Target / mechanism
beta-amyloid plaques and tau neurofibrillary tangle aggregates PMID 29855843
Clinical application
Alzheimer's disease and non-AD tauopathies PMID 39762194
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
40-60%>99%2-{[6-(2,2-dicyano-1-methylvinyl)-2-naphthyl](methyl)amino}ethyl-4-methylbenzenesulfonate (DDNPTs)17051324
2007 Mol Imaging Biol

Need this precursor?We can point you to suppliers for [18F]FDDNP, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]FDDNP.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18. | Stage 28: added indication(s) neu-tbi, psy-mood from consolidated missing-rubric review.